NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
−1.06%Leverage
- Debt / equity
- 0.23x
- Net debt / equity
- 0.14x
- Debt / assets
- 0.18x
- Debt / EBITDA
- -0.49x
- Net debt / EBITDA
- -0.30x
Liquidity & coverage
- Current ratio
- 9.25x
- Quick ratio
- 9.25x
- Cash ratio
- 8.87x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $80.5M
Cash & dividend
- FCF / debt
- -2.06x
- Cash flow / debt
- -1.96x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026